These data indicate that FAK and c-Myc synergistically drive tumor cell survival largely by decreasing the cellular level of Bim or the ratios of Bim/Bcl2 + Bcl-xl, regardless the endogenous level of Bim. This evidence concerns the gene BCL2L11 and neoplasm.